Key Quantitative Figures
The Nomination and Remuneration Committee (NRC) approved the grant of 250,000 (Two Lakhs Fifty Thousands) stock options. Each option is convertible into one equity share of the company with a face value of ₹10. The exercise price for the options is set at ₹10 per option.
Dates of Action
The NRC meeting was held on August 10, 2026. The meeting commenced at 11:15 AM IST and concluded at 11:50 AM IST. The effective grant date for the options is the date of approval, i.e., August 10, 2026.
Parties Involved
The grant was approved by the Nomination and Remuneration Committee of Yatharth Hospital & Trauma Care Services Limited. The options are granted to eligible employees of the company. The disclosure was signed by Ritesh Mishra, Company Secretary & Compliance Officer (Membership No. A51166).
Vesting and Exercise Details
The vesting period shall commence from a period of one year from the grant date (August 10, 2026) and extend up to a maximum period of four years from the grant date, at the discretion of the Committee. After vesting, options can be exercised either wholly or partly within a maximum exercise period of two years from the date of respective vesting. The Committee may open an Exercise Window during the overall exercise period. In the event of death or permanent disability of a grantee, the minimum one-year vesting period is waived, and options vest immediately as per SEBI regulations.
Financial and Capital Structure Impact
If all 250,000 granted options are vested and exercised, it will result in the issuance of 250,000 new equity shares of face value ₹10 each through a fresh allotment from the company.
Additional Information
The disclosure and a copy of the ESOP scheme will be made available on the company's website at https://www.yatharthhospitals.com/investors.